Chinese conglomerate
Hengdian Group (Chinese: 横店集团[8]), abbreviated as HG,[9] is a Chinese private conglomerate founded by Xu Wenrong[10] in 1975 in Hengdian, Zhejiang.[11] It focuses on the fields of electrical and electronic,[12] pharmaceutical and chemical,[13] film and entertainment,[14] and modern services.[15] Since 1996,[16] Hengdian Group has operated Hengdian World Studios.[17]
History
In 1975, Xu Wenrong set up Hengdian Reeling Silk Factory,[18] which was the predecessor of Hengdian Group. In the 1990s, it expanded into high-tech sectors such as hard magnets, soft magnets, and pharmaceutical manufacturing.[19]
In 2004, Hengdian Group, Warner Bros. and China Film Group Corporation[20] established the Warner China Film HG,[21] which is a joint venture.[22] In 2008, it established the Zhejiang Hengdian Film Production Company.[23]
In 1989, Hengdian group founded Apeloa Pharmaceutical, which was listed on the Shenzhen Stock Exchange in 1997, covers active pharmaceutical ingredients and intermediates, pesticides, medical devices and medical services.
Hengdian Group also expanded into the lighting field in late 1990s，covering light-emitting diode fixtures, lighting sources, smart lighting and automotive lighting.[24]
In 2017, Tospo Lighting Co., Ltd., a subsidiary of Hengdian Group, completed an IPO on the Shanghai Stock Exchange.[25]
In August 2019, Nanhua Futures, a subsidiary of Hengdian Group, was listed on the Shanghai Stock Exchange.[26]
In December 2021, Hengdian DMEGC, a public subsidiary of Hengdian Group,[27]
planned to form a joint venture with Japan's Foster Electric Co. in Vietnam for the manufacturing of ferrite magnets.[28]
In November 2022, DMEGC signed an investment deal with Yibin, Sichuan to construct a 20 GW TOPCon cell factory in three phases for CNY 10bn ($1.41bn).
[29]
In March 2022, Apeloa Pharmaceutical Co., a public subsidiary of Hengdian Group, [30]
have signed on with UN-backed public health organization Medicines Patent Pool (MPP)to manufacture the generic version of Pfizer's oral COVID-19 treatment, nirmatrelvir. [31]
In July 2022, Hengdian Entertainment, one of the listed companies of Hengdian group, offered RMB 3 billion ($446 millon) to acquire Shanghai Xingyi Cinema Managements.[32]
Business areas
Electrical and Electronic
·DMEGC Magnetics [33]
·Tospo Lighting [34]
Pharmaceutical and Healthcare
·Apeloa Pharmaceutical[35]
Film and Entertainment
·Hengdian Entertainment [36]
·Hengdian World Studios [37]
Modern Services
·Nanhua Futures[38]
CNY88.6 billion[6] (2022)